This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Matthew Majewski

Vice President

Mr. Matthew Majewski has a track record of providing life science clients with analytically based solutions to their strategic issues.

He has led a wide range of corporate and asset-specific strategy engagements, many of which have focused on pricing and market access. Mr. Majewski has deep experience in the specialty disease space and has provided insights to many clients with rare disease, oncology, and cell & gene therapy assets across the retail, specialty, and hospital channels. Prior to joining CRA, Mr. Majewski was a consultant at a biopharmaceutical organization where he developed and managed market strategies for pre-launch products and designed and managed market organizations.

Related capabilities
Related capabilities

Selected engagements

  • 01
    Identified key trial design opportunities for a unique acute ischemic stroke treatment
    A leading pharmaceutical company sought support from CRA’s Life Sciences experts in understanding payer and hospital access decision maker (HADM) perspectives
    View engagement
  • 02
    Developing market-access focused segmentation and typing tool to aid uptake of bispecific oncology products
    A leading pharmaceutical company sought support from CRA’s Life Sciences consultants in understanding how to best segment, target, and activate key access
    View engagement
  • 03
    Establishing real-world testing and treatment patterns for EGFR NSCLC patients
    Oncology-focused biotech was looking to establish real-world testing and treatment patterns among EGFR NSCLC patients in US, EU, Japan, and Greater China...
    View engagement

Latest insights

Recent events

Credentials

Get In Touch
Matthew Majewski
New York +1-212-520-7260 mmajewski@crai.com